BGB-102

• Target:

  FLT|||VEGFR|||EGFR|||Src

• Related Pathways:

  Tyrosine Kinase/Adaptors|||Angiogenesis|||JAK/STAT signaling

• Purity:

  0.9902

• Bioactivity:

  BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.

• Smiles:

  BrC1=CC=C2C(=C1)NC=3N=CN=C4C=C(OC)C(OCCCCCN(C)C2)=CC43

• Molecular Formula:

  C22H25BrN4O2

• Molecular Weight:

  457.36

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  807640-87-5